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Background
We wanted to examine how disclosure of the HIV posi-
tive status modifies risky behaviors and drug use in
patients in substitution at the ARENA center from the
National Institute for Infectious Diseases “Prof. Dr.
Matei Balş”, Bucharest.
Methods
The prospective study enrolled 94 patients diagnosed
with HIV after IV consumption of “legal highs” and
being in oral substitution treatment since March 2012.
The final analysis included 71 patients who were in
treatment in the range of 15 months from the initiation
of the study and answered at least 2 of the quarterly
surveys. All patients had urine tests done monthly.
Results
13 of the patients (18.3%) were women; the average age
was 31.2 years with an average IV drug use of 8.7 years, of
which 19 months with legal highs also. The average num-
ber of relapses per patient prior to the study period was
4.7, due to lack of participation to psychotherapy. Only
17 patients (24%) managed to quit legal highs consump-
tion in the studied period. 15 patients (21%) were out of
therapy for a period of over 21 days within the study per-
iod. Most of them are with low literacy (6.2 grades), 91%
were incarcerated. Of the 24 patients in antiretroviral
treatment, 3 dropped out of therapy. Only 7 patients had
positive urine test for opiates, but other 47 had recognized
legal highs intermittent consumption.
Conclusion
Paradoxically, disclosing the HIV-positive status, with all
the counseling and even involving free access to substitu-
tion therapy, caused relapse in the majority of patients.
The main idea is that if they are going to die, at least to
die “drugged and happy”. On the other hand this signals
the need for new approaches in counseling.
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